Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Foto på Patrik Edén

Patrik Edén

Universitetslektor

Foto på Patrik Edén

Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations

Författare

  • Anna Andersson
  • Patrik Edén
  • David Lindgren
  • Jens Nilsson
  • Carin Lassen
  • Jesper Heldrup
  • Magnus Fontes
  • Åke Borg
  • Felix Mitelman
  • Bertil Johansson
  • Mattias Höglund
  • Thoas Fioretos

Summary, in English

Hematologic malignancies are characterized by fusion genes of biological/clinical importance. Immortalized cell lines with such aberrations are today widely used to model different aspects of leukemogenesis. Using cDNA microarrays, we determined the gene expression profiles of 40 cell lines as well as of primary leukemias harboring 11q23/MLL rearrangements, t(1;19)[TCF3/PBX1], t(12;21)[ETV6/RUNX1], t(8;21)[RUNX1/CBFA2T1], t(8;14) [IGH@/MYC], t(8;14)[TRA@/MYC], t(9;22)[BCR/ABL1], t(10;11) [PICALM/MLLT10], t(15;17)[PML/RARA], or inv(16)[CBFB/MYH11]. Unsupervised classification revealed that hematopoietic cell lines of diverse origin, but with the same primary genetic changes, segregated together, suggesting that pathogenetically important regulatory networks remain conserved despite numerous passages. Moreover, primary leukemias cosegregated with cell lines carrying identical genetic rearrangements, further supporting that critical regulatory pathways remain intact in hematopoietic cell lines. Transcriptional signatures correlating with clinical subtypes/primary genetic changes were identified and annotated based on their biological/molecular properties and chromosomal localization. Furthermore, the expression profile of tyrosine kinase-encoding genes was investigated, identifying several differentially expressed members, segregating with primary genetic changes, which may be targeted with tyrosine kinase inhibitors. The identified conserved signatures are likely to reflect regulatory networks of importance for the transforming abilities of the primary genetic changes and offer important pathogenetic insights as well as a number of targets for future rational drug design.

Avdelning/ar

  • Avdelningen för klinisk genetik
  • Beräkningsbiologi och biologisk fysik - Har omorganiserats
  • Bröstcancer-genetik
  • Matematik LTH
  • Pediatrik, Lund
  • MLL-rearrangerad leukemi hos spädbarn

Publiceringsår

2005

Språk

Engelska

Sidor

1042-1050

Publikation/Tidskrift/Serie

Leukemia

Volym

19

Issue

6

Dokumenttyp

Artikel i tidskrift

Förlag

Nature Publishing Group

Ämne

  • Cancer and Oncology

Nyckelord

  • cDNA microarray
  • AML
  • CML-BC
  • ALL
  • pediatric leukemia

Status

Published

Forskningsgrupp

  • The pathogenetic mechanisms behind MLL-rearranged acute leukemia in infancy

ISBN/ISSN/Övrigt

  • ISSN: 1476-5551